Search

everythinglearnresearchcommunity

for

Search:↓

The best shampoo formula used 1% high-weight hyaluronic acid, 10% acidic sophorolipid, and 1% salt for effective hair conditioning and cleansing without sulfates or silicones.

Low-dose oral minoxidil helps hair regrowth in COVID-19-related hair loss with few side effects.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

A 16-year-old boy's arm hair grew more after wearing a splint, but it returned to normal in 8 months.

Cyproterone acetate at 2mg daily is as effective as higher doses for treating excessive hair growth in women.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

New treatments are available for managing ingrown hair inflammation.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

Poor sleep during the pandemic may increase stress and worsen hair loss conditions.

Wound tension after hair transplant surgery increases with strip size and is higher on the sides, affecting scarring.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Platelet-rich fibrin might be a promising treatment for hair loss, but more research is needed to confirm its effectiveness.

The study concluded that the developed models are effective for studying hair growth mechanisms and testing new treatments.

Telogen effluvium is a common, distressing condition causing excessive hair shedding and has significant psychological effects on patients.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Different botulinum toxin products and concentrations can effectively reduce sweating, itching, bladder pressure, hair loss, and muscle spasms.

Prolonged use of topical corticosteroids can cause excessive hair growth.

Iron deficiency may contribute to chronic hair loss in premenopausal women.

AGA and TE can be differentiated by specific trichoscopic features, with AGA showing more variation in hair thickness in fronto-temporal areas.

Cyclosporine A slows down hair loss from chemotherapy in mice, while dexamethasone increases hair loss but speeds up regrowth.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Dr. Parsa Mohebi created a new tool to improve hair transplant efficiency and reduce follicle damage.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.